A Prospective Evaluation of Tocilizumab in Patients With Rheumatoid Arthritis Refractory to Conventional Disease-Modifying Anti-Rheumatic Medications (DMARDs)
Cureus. 2025 Sep 22;17(9):e92922. doi: 10.7759/cureus.92922. eCollection 2025 Sep. ABSTRACT BACKGROUND: Rheumatoid arthritis (RA) refractory to conventional synthetic disease-modifying anti-rheumatic […]
